Contract Pharmacies Have Proliferated, Conservative Group Says, Citing Data from Pharma-Funded Think Tank

A Paragon Health Institute analysis found the share of 340B contract pharmacies per covered entity has increased in recent years.
Active 340B contract pharmacies reached 17,250 in 2024, according to a conservative think tank using data collected by another group funded by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Four More Drugmakers to End 340B Contract Pharmacy Restrictions in Arkansas Following Appeals Court Decision

At least nine drugmakers have modified their contract pharmacy restrictions in Arkansas after the state said it planned to enforce its 340B law following an appeals court decision. An additional nine manufacturers loosened restrictions prior to the court decision.
Bristol Myers Squibb (BMS), Amgen, and Bayer became the latest drugmakers to formally exempt Arkansas providers from their 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sumitomo Is Thirty-Second Company to Implement Contract Pharmacy Restrictions

Sumitomo is the 32nd pharmaceutical manufacturer to place restrictions on 340B drug shipment in the contract pharmacy setting.
Drugmaker Sumitomo Pharma America (SMPA) announced it will implement first-time contract pharmacy restrictions next month. The biotech company, which is [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Astellas Adds Second Drug to 340B Contract Pharmacy Restrictions

Pharmaceutical manufacturer Astellas recently added a second medication to its 340B contract pharmacy restrictions.
Japanese drugmaker Astellas will soon extend its limits on 340B pricing to hospitals for its medication to treat overreactive bladder, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amgen, J&J to Issue Refunds on High-Selling Drugs to 340B Providers

Drugmakers Amgen and Johnson & Johnson have announced they will provide refunds to 340B providers on past purchases of multiple [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Estimated 340B Revenue Exceeded Charity Care Spending for 85% of DSH Hospitals, Says Pharma-backed Group

340B revenue exceeds charity care spending for most DSH hospitals, said a report from drug industry-backed AIR340B.
Eighty-five percent of DSH hospitals earned more in estimated 340B revenue in 2022 than they incurred in charity care costs, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As Arkansas Prepares to Enforce 340B Contract Pharmacy Law, Major Drugmaker Files Suit and PhRMA Plans to Seek 8th Circuit Rehearing

Drugmaker AstraZeneca filed suit against Arkansas' 340B contract pharmacy law, shortly after it was upheld by a federal appeals court.
After a federal appeals court upheld Arkansas’ 340B contract pharmacy access law, a major drug manufacturer has asked a federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Judge Dismisses Health System’s Penny Pricing Coordination Lawsuit Against Drugmakers

A federal district judge has dismissed Calif.-based Adventist West's lawsuit against four drug manufacturers.
A federal judge recently dismissed a large California health system’s whistleblower case against four pharmaceutical companies for alleged fraudulent 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two More Drugmakers End 340B Contract Pharmacy Restrictions in Arkansas After Appeals Court Decision

EMD Serono lifted 340B contract pharmacy restrictions in Arkansas in response to a state law. Shortly after, Sanofi also updated its policy in the state.
Drugmakers EMD Serono and Sanofi will lift 340B contract pharmacy restrictions in Arkansas after a federal appeals court upheld a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two More Drug Companies Restore 340B Contract Pharmacy Access in Arkansas After Court Decision; Enforcement Action Imminent Against Others

As AID prepares to initiate enforcement of Arkansas' 340B contract pharmacy law, two more drugmakers announced they would exempt state providers from their contract pharmacy policies.
Months after nine drug manufacturers restored 340B contract pharmacy access in Arkansas, two more companies have announced they will exempt [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live